Statin use and risk of vascular events among cancer patients after radiotherapy to the thorax, head, and neck

62Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background This study aimed to explore whether statins reduce radiation-induced vascular complications in cancer patients postradiotherapy to the thorax, head, and neck. Methods and Results We conducted a retrospective cohort study within a provincial linked database of 5718 cardiac patients with thorax and head or neck cancer having undergone radiotherapy between 2000 and 2011. One thousand five hundred fifty-two patients were identified as nonstatin users and 4166 as statin users. The primary outcome of interest was the composite of cerebrovascular (transient ischemic attack, and fatal or nonfatal stroke) or cardiovascular events (fatal or nonfatal myocardial infarction). Time-dependent Cox proportional hazard analyses were performed. The crude event rate was 10.31% for nonusers and 9.03% for statin users (hazard ratio of 0.92 [95% CI 0.76-1.10, P=0.3451]), over a mean time to event/censoring of 534±687 days for nonusers and 594±706 days for the statin users. After adjusting for age, sex, prior history of stroke/transient ischemic attack or myocardial infarction, diabetes mellitus, dyslipidemia, atrial fibrillation, chronic kidney disease, heart failure, and hypertension, statin use postradiotherapy was associated with a nonsignificant 15% relative risk reduction, but a strong trend toward reducing the primary outcome (hazard ratio=0.85 95% CI 0.69-1.04, P=0.0811). The use of statins was associated with a significant reduction of 32% for the outcome of stroke alone (hazard ratio=0.68, 95% CI 0.48-0.98, P=0.0368). Conclusions Statin use post radiation therapy was associated with a significant reduction in stroke, with a trend toward significantly reducing cardiovascular and cerebrovascular events.

References Powered by Scopus

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

3211Citations
N/AReaders
Get full text

High-dose atorvastatin after stroke or transient ischemic attack

2592Citations
N/AReaders
Get full text

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials

2356Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society

136Citations
N/AReaders
Get full text

Cancer and Embolic Stroke of Undetermined Source

106Citations
N/AReaders
Get full text

The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review

97Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Boulet, J., Peña, J., Hulten, E. A., Neilan, T. G., Dragomir, A., Freeman, C., … Mousavi, N. (2019). Statin use and risk of vascular events among cancer patients after radiotherapy to the thorax, head, and neck. Journal of the American Heart Association, 8(13). https://doi.org/10.1161/JAHA.117.005996

Readers over time

‘18‘19‘20‘21‘22‘23‘24‘2505101520

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

66%

Researcher 6

21%

Professor / Associate Prof. 3

10%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 31

84%

Pharmacology, Toxicology and Pharmaceut... 2

5%

Chemistry 2

5%

Nursing and Health Professions 2

5%

Article Metrics

Tooltip
Mentions
News Mentions: 11
Social Media
Shares, Likes & Comments: 37

Save time finding and organizing research with Mendeley

Sign up for free
0